KALOS THERAPEUTICS INC has a total of 13 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2008. It filed its patents most often in Japan, Canada and China. Its main competitors in its focus markets pharmaceuticals and biotechnology are PENTRAXIN THERAPEUTICS LTD, NEUREN PHARMACEUTICALS LTD and JIANGSU HAOSEN PHARMACEUTICAL.
# | Country | Total Patents | |
---|---|---|---|
#1 | Japan | 3 | |
#2 | Canada | 2 | |
#3 | China | 2 | |
#4 | EPO (European Patent Office) | 2 | |
#5 | WIPO (World Intellectual Property Organization) | 2 | |
#6 | Hong Kong | 1 | |
#7 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Kozlowski Michael | 7 |
#2 | Kozlowski Michael R | 5 |
#3 | Michael Kozlowski | 1 |
Publication | Filing date | Title |
---|---|---|
CN108653715A | The method and purposes of ANP, BNP and CNP related peptide and its derivative for treating retinal disorder and disease | |
CA2710920A1 | Anti-proliferative compounds and their use |